OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin and Alzheimer’s Disease: A New Perspective
Yoo Hyun Um, Hyun Kook Lim
Psychiatry Investigation (2020) Vol. 17, Iss. 7, pp. 621-626
Open Access | Times Cited: 25

Showing 25 citing articles:

Drug Discovery and Development Targeting Dementia
Agnieszka Zagórska, Anna Czopek, Monika Fryc, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 151-151
Open Access | Times Cited: 20

Pharmacological Management of Apathy in Dementia
Laiba Azhar, Raphael W. Kusumo, Giovanni Marotta, et al.
CNS Drugs (2022) Vol. 36, Iss. 2, pp. 143-165
Closed Access | Times Cited: 26

Sleep–Wake Disorders in Alzheimer’s Disease: A Review
Yu-Ying Sun, Zhun Wang, He-Yan Zhou, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 10, pp. 1467-1478
Closed Access | Times Cited: 19

Effect of a dual orexin receptor antagonist on Alzheimer's disease: Sleep disorders and cognition
Mengzhen Zhou, Shi Tang
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 13

Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access

Hippocampal orexin receptors: Localization and function
Mahmoud Elahdadi Salmani, Masoumeh Sarfi, Iran Goudarzi
Vitamins and hormones (2022), pp. 393-421
Closed Access | Times Cited: 18

Acupuncture Interventions for Alzheimer’s Disease and Vascular Cognitive Disorders: A Review of Mechanisms
Kunrui Du, Shaojie Yang, Jingji Wang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 18

Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice
Peng Zhao, Yaqian You, Zhe Wang, et al.
Brain Structure and Function (2022) Vol. 227, Iss. 3, pp. 1051-1065
Open Access | Times Cited: 17

The interaction between orexin, sleep deprivation and Alzheimer’s disease: Unveiling an Emerging Connection
Masoumeh Kourosh‐Arami, Mahdi Ramezani, Alireza Komaki‬
The Journal of Physiological Sciences (2025) Vol. 75, Iss. 1, pp. 100004-100004
Open Access

Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.
Isidró Ferrer
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 3
Closed Access | Times Cited: 16

Role of astrocytes in sleep deprivation: accomplices, resisters, or bystanders?
Mengxin Que, Yujuan Li, Xuan Wang, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9

Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer’s disease
Ashish Dhiman, Mayank Handa, Munindra Ruwali, et al.
Mitochondrion (2022) Vol. 64, pp. 112-124
Closed Access | Times Cited: 12

Relationship between APOE, PER2, PER3 and OX2R Genetic Variants and Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease
Susana Lozano-Tovar, Yaneth Rodríguez‐Agudelo, David José Dávila‐Ortiz de Montellano, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4412-4412
Open Access | Times Cited: 5

Ghrelin system in Alzheimer's disease
Jing Tian, Tienju Wang, Heng Du
Current Opinion in Neurobiology (2022) Vol. 78, pp. 102655-102655
Open Access | Times Cited: 7

Orexin receptors: Targets and applications
Subhiksha Subramanian, Mirunalini Ravichandran
Fundamental and Clinical Pharmacology (2021) Vol. 36, Iss. 1, pp. 72-80
Closed Access | Times Cited: 7

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer’s Disease
Joan Biel Rebassa, Toni Capó, Jaume Lillo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5378-5378
Open Access

Effect of different doses of almorexant on learning and memory in 8-month-old APP/PS1 (AD) mice
Mengzhen Zhou, Yanran Li
Peptides (2023) Vol. 167, pp. 171044-171044
Closed Access | Times Cited: 1

The Relationship between Sleep Disturbance and Early Alzheimer's Disease – Mild Cognitive Impairment
Mengzhen Zhou
Neuroscience and Neurological Surgery (2024) Vol. 14, Iss. 1, pp. 01-06
Open Access

Bibliometric analysis of orexin: A promising neuropeptide
Ning Sun, Rui Wei, Bochao Jia, et al.
Medicine (2024) Vol. 103, Iss. 43, pp. e40213-e40213
Open Access

Lemborexant (Dayvigo)
CADTH
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 4
Open Access

Las orexinas como biomarcadores para demencia tipo Alzheimer y relación con síntomas neuropsiquiátricos
Susana Lozano-Tovar, Nancy Monroy‐Jaramillo, Yaneth Rodríguez‐Agudelo
Revista chilena de neuro-psiquiatría (2022) Vol. 60, Iss. 3, pp. 313-324
Open Access

Page 1

Scroll to top